Flex Pharma

Developer of therapeutics for neuromuscular disorders

placeBoston, Massachusetts, United States calendar_todayFounded 2014 groups34 employees language flex-pharma.com

Registered entities

Investor mix

13 investors on record; lead investors include Longwood Fund, Bessemer Venture Partners, EcoR1, Lightstone Ventures; 1 has since exited.

Investor typeCountShare
Venture capital646%
Private equity18%
Angel & family office18%
Other / undisclosed538%
Coming soon